Kednapa Thavorn

Dr. Kednapa Thavorn

Co-Applicant

Associate Professor of Epidemiology and Public Health at uOttawa | Senior Scientist and Scientific Lead of Health Economics at the Ottawa Hospital Research Institute

Adjunct Scientist at ICES


NMD4C Involvement: Pillar 3: Clinical Practice Research

Email Kednapa

Research Interests: Pharmacoeconomics, Health Economics, Pharmacoepidemiology, Outcome Research

Academic web profile
Google Scholar profile
LinkedIn profile
ResearchGate profile
ORCiD profile

Biography

Dr. Kednapa Thavorn is a Senior Scientist and a Scientific Lead of Health Economics at the Ottawa Hospital Research Institute. She is also an Associate Professor with the School of Epidemiology and Public Health at the University of Ottawa, an Adjunct Scientist at ICES (Full Status). She holds a Ph.D. in Health Services Research from the Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto. She completed post-doctoral fellowship programs in Applied Pharmacoeconomics from the Li Ka Shing Knowledge Institute, St. Michael’s Hospital and Health Services Research from the IHPME, University of Toronto. Her research focuses on health economics, health technology assessment, pharmacoepidemiology, health equity, care for people with complex needs, and population health. As a health economist, she has collaborated with patient partners, clinicians, researchers, and policymakers in Canada and other countries on various health services research and health technology assessment projects.  


Recent Publications

Bjerre, LM, Smith, G, Catley, C, Halil, R, Ramsay, T, Cahir, C et al.. Association between potentially inappropriate prescribing and adverse patient outcomes using codified STOPP-START and Beers criteria in large, routinely collected population health datasets: a retrospective cohort study. J Clin Epidemiol. 2026. 112246 PMID:41865806

Kendzerska, T, Pendharkar, SR, Talarico, R, Luks, V, Chandy, G, Mulpuru, S et al.. Evaluating the Role of Inpatient Sleep Studies in Hospitalized Adults in Relation to One-Year Mortality and Healthcare Utilization: A Population-Based Cohort Study. Ann Am Thorac Soc. 2026. PMID:41837369

Masucci, L, Schwartz, K, Ivers, N, Bai, L, Brown, K, Tadrous, M et al.. Mailed Audit and Feedback for Antibiotic Prescribing in Primary Care. JAMA Netw Open. 2026.9 (3)e261641 PMID:41823966

Dowson, M, Thavorn, K, Palumbo, A, Willows, M, Suschinsky, K, Garner, G et al.. What Matters Most When Visiting a Rapid Access Addiction Medicine Clinic in Canada for Alcohol Use Care: A National eDelphi Study: Ce qui compte le plus lorsque l'on visite une clinique d'accès rapide au traitement médical de la toxicomanie (RAAM) au Canada pour des soins liés à la consommation d'alcool : une étude eDelphi nationale. Can J Psychiatry. 2026. 7067437251412555 PMID:41671160

Curry, T, Wener, E, Odell, M, Caulley, L, Ramchandani, R, Grant, A et al.. Choice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario. Laryngoscope. 2026. PMID:41636338

Bugeja, A, Scarffe, A, Agarwal, A, Clark, EG, Burns, K, McDougall, J et al.. An Economic Evaluation of a One-Day Living Kidney Donor Evaluation Process Compared to the Usual Approach. Am J Kidney Dis. 2026. PMID:41628814

Grant, A, Kabbani, D, Vuong, A, Skidmore, B, Hsu, AT, Sanmugalingham, G et al.. Value of Emerging and Existing Pre-prophylaxis and Therapeutic Options for COVID-19 in Transplant Recipients: A Systematic Review of Economic Evaluations. Pharmacoecon Open. 2026. PMID:41612083

Giguère, P, Akbarian, N, Prince, C, Thavorn, K, Cieniak, C, Granger, M et al.. Late Immune Effector Cell-Associated Hematologic Toxicity After CD19 CAR-T Therapy: Incidence, Clinical Course, and Resource Utilization. Eur J Haematol. 2026. PMID:41545019

Andersen, CR, Fernie, G, Presseau, J, Shea, B, Marti, ML, Hostettler, IC et al.. International Position Paper on Outcome Selection After Aneurysmal Subarachnoid Hemorrhage. Stroke. 2026.57 (2)560-567 PMID:41498145

Poirier, MJ, Singh, J, Weldon, I, Chandler, CI, Corno, D, Valtere, L et al.. Social science contributions to the global action plan on antimicrobial resistance. Bull World Health Organ. 2026.104 (1)53-55 PMID:41409099

See more on PubMed